Fidelis Capital Partners, LLC Incyte Corp Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 566 shares of INCY stock, worth $37,282. This represents 0.05% of its overall portfolio holdings.
Number of Shares
566Holding current value
$37,282% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
619Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.38 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.53 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.5 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$1.02 Billion0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$652 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.7B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...